MedTrace Logo

The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section

NCT05975112 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 780

Last updated 2024-03-21

No results posted yet for this study

Summary

This study aims to find out if there are common major changes in coagulation immediately after delivery of the newborn during Cesarean (C) -section and vaginal birth.

Conditions

  • Hyperfibrinolysis
  • Cesarean Section Complications
  • Coagulation Defect; Bleeding
  • Peripartum Haemorrhage

Interventions

DIAGNOSTIC_TEST

Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge

Coagulation tests named earlier as well as SpHb

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-11-30
Completion
2025-04-17

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05975112 on ClinicalTrials.gov